INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 211 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,493 | -41.0% | 28,660 | -28.3% | 0.01% | -33.3% |
| Q2 2023 | $2,530 | -99.0% | 39,958 | +482.6% | 0.02% | +600.0% |
| Q3 2021 | $256,000 | -88.1% | 6,859 | -91.8% | 0.00% | -93.0% |
| Q3 2020 | $2,156,000 | +280.9% | 84,027 | +409.6% | 0.04% | +290.9% |
| Q4 2019 | $566,000 | +515.2% | 16,490 | +33.2% | 0.01% | +266.7% |
| Q3 2019 | $92,000 | -32.8% | 12,382 | +17.6% | 0.00% | -40.0% |
| Q2 2019 | $137,000 | – | 10,525 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |